Severe Achromobacter xylosoxidans infection and loss of sputum bacterial diversity in an adult patient with cystic fibrosis

被引：10
|
作者：
Talbot, Nick P. [1 ,2 ]
Flight, William G. [1 ]
机构：
[1] Oxford Univ Hosp NHS Fdn Trust, Oxford Adult Cyst Fibrosis Ctr, Oxford, England
[2] Univ Oxford, Nuffield Dept Med, Oxford OX1 2JD, England
来源：
PAEDIATRIC RESPIRATORY REVIEWS | 2016年 / 20卷
关键词：
Cystic fibrosis; Achromobacter xylosoxidans; Sputum microbiome; Cross-infection; ALCALIGENES-XYLOSOXIDANS; COLONIZATION; PREVALENCE;
D O I：
10.1016/j.prrv.2016.06.011
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
Achromobacter spp. are emerging pathogens in the lungs of patients with cystic fibrosis. We report the case of an adult patient with cystic fibrosis and chronic A. xylosoxidans infection who experienced rapid, progressive clinical deterioration. Metagenomic analysis of the sputum revealed that the airway microbiota was almost entirely dominated by A. xylosoxidans. We review the impact of this organism on lung function and the airway microbiome in cystic fibrosis, and discuss the potential for cross-infection between patients. (C) 2016 Elsevier Ltd. All rights reserved.
引用
收藏
页码：27 / 29
页数：3
相关论文
共 50 条
  • [1] Achromobacter xylosoxidans infection in an adult cystic fibrosis unit in Madrid
    Llorca Otero, Laura
    Giron Moreno, Rosa
    Buendia Moreno, Buenaventura
    Valenzuela, Claudia
    Guiu Martinez, Alba
    Alarcon Cavero, Teresa
    ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA, 2016, 34 (03): : 184 - 187
  • [2] Achromobacter xylosoxidans respiratory tract infection in cystic fibrosis patients
    A. Lambiase
    M. R. Catania
    M. del Pezzo
    F. Rossano
    V. Terlizzi
    A. Sepe
    V. Raia
    European Journal of Clinical Microbiology & Infectious Diseases, 2011, 30 : 973 - 980
  • [3] Achromobacter xylosoxidans respiratory tract infection in cystic fibrosis patients
    Lambiase, A.
    Catania, M. R.
    del Pezzo, M.
    Rossano, F.
    Terlizzi, V.
    Sepe, A.
    Raia, V.
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2011, 30 (08) : 973 - 980
  • [4] Phage therapy against Achromobacter xylosoxidans lung infection in a patient with cystic fibrosis: a case report
    Hoyle, N.
    Zhvaniya, P.
    Balarjishvili, N.
    Bolkvadze, D.
    Nadareishvili, L.
    Nizharadze, D.
    Wittmann, J.
    Rohde, C.
    Kutateladze, M.
    RESEARCH IN MICROBIOLOGY, 2018, 169 (09) : 540 - 542
  • [5] Hypermutation as an Evolutionary Mechanism for Achromobacter xylosoxidans in Cystic Fibrosis Lung Infection
    Veschetti, Laura
    Sandri, Angela
    Johansen, Helle Krogh
    Lleo, Maria M.
    Malerba, Giovanni
    PATHOGENS, 2020, 9 (02):
  • [6] ACHROMOBACTER XYLOSOXIDANS INFECTION RATE AND CLINICAL OUTCOMES IN A CYSTIC FIBROSIS CENTER
    Duval, M. A.
    Maxa, K.
    Sedor, J.
    PEDIATRIC PULMONOLOGY, 2013, 48 : 331 - 331
  • [7] Clinical impact of Achromobacter xylosoxidans colonization/infection in patients with cystic fibrosis
    Firmida, M. C.
    Pereira, R. H. V.
    Silva, E. A. S. R.
    Marques, E. A.
    Lopes, A. J.
    BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH, 2016, 49 (04)
  • [8] Achromobacter xylosoxidans isolated from the sputum of a patient with cystic fibrosis mutation I1234V with Pseudomonas aeruginosa
    Wahab, AA
    Janahi, IA
    El-Shafie, SS
    SAUDI MEDICAL JOURNAL, 2004, 25 (06) : 810 - 811
  • [9] Sepsis Caused by Achromobacter Xylosoxidans in a Child with Cystic Fibrosis and Severe Lung Disease
    Stobbelaar, Kim
    Van Hoorenbeeck, Kim
    Lequesne, Monique
    De Dooy, Jozef
    Ho, Erwin
    Vlieghe, Erik
    Ieven, Margaretha
    Verhulst, Stijn
    AMERICAN JOURNAL OF CASE REPORTS, 2016, 17 : 562 - 566
  • [10] Impact of Achromobacter xylosoxidans isolation on the respiratory function of adult patients with cystic fibrosis
    Tetart, Macha
    Wallet, Frederic
    Kyheng, Maeva
    Leroy, Sylvie
    Perez, Thierry
    Le Rouzic, Olivier
    Wallaert, Benoit
    Prevotat, Anne
    ERJ OPEN RESEARCH, 2019, 5 (04)
12345